Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ) announced a profit for its first quarter that Increased, from last year
The company's bottom line totaled RMB95.17 million, or RMB0.1681 per share. This compares with RMB75.67 million, or RMB0.1425 per share, last year.
The company's revenue for the period rose 0.6% to RMB405.25 million from RMB403.01 million last year.
Tibet Cheezheng Tibetan Medicine Co., Ltd. earnings at a glance (GAAP) :
-Earnings: RMB95.17 Mln. vs. RMB75.67 Mln. last year.-EPS: RMB0.1681 vs. RMB0.1425 last year.-Revenue: RMB405.25 Mln vs. RMB403.01 Mln last year.
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.